These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Overcoming institutional and community resistance to a tardive dyskinesia management program. Wolf ME; Brown P Hosp Community Psychiatry; 1987 Jan; 38(1):65-8. PubMed ID: 2879787 [TBL] [Abstract][Full Text] [Related]
10. Informed consent and tardive dyskinesia. Long-term follow-up. Kleinman I; Schachter D; Jeffries J; Goldhamer P J Nerv Ment Dis; 1996 Sep; 184(9):517-22. PubMed ID: 8831640 [TBL] [Abstract][Full Text] [Related]
11. Informing patients about tardive dyskinesia: four-year follow up of a trial of patient education. Chaplin R; Timehin C Aust N Z J Psychiatry; 2002 Feb; 36(1):99-103. PubMed ID: 11929445 [TBL] [Abstract][Full Text] [Related]
12. Psychiatrists' attitudes about and informed consent practices for antipsychotics and tardive dyskinesia. Schachter DC; Kleinman I Psychiatr Serv; 2004 Jun; 55(6):714-7. PubMed ID: 15175474 [TBL] [Abstract][Full Text] [Related]
13. Comparison of severe and mild tardive dyskinesia: implications for etiology. Gardos G; Cole JO; Schniebolk S; Salomon M J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550 [TBL] [Abstract][Full Text] [Related]
20. [Medicolegal aspects of tardive dyskinesia in the United States]. Wolf MA; Grunberg F; Garneau Y Encephale; 1988; 14(3):133-8. PubMed ID: 2900134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]